Literature DB >> 21113936

Chemoresistant hepatoblastoma in a patient with mosaic trisomy 18 treated with orthotopic liver transplantation.

Karen S Fernandez1, Rebecca Baum, Bonita Fung, Nicholas Yeager, Mike A Leonis, Lars M Wagner, Greg Tiao, Mary E Ross.   

Abstract

We present a 9-month-old male with mosaic trisomy 18 with a right hepatic lobe mass. The tumor was completely resected and identified as pure fetal histology hepatoblastoma but contained increased mitotic activity. Adjuvant chemotherapy consisted of cisplatin, vincristine, and 5-fluorouracil. After the first and fourth cycles of chemotherapy, recurrent tumor developed. The patient underwent rescue orthotopic liver transplantation, and is currently alive without evidence of hepatoblastoma 28 months after transplantation. This report demonstrates the use of orthotopic liver transplantation in a child with mosaic trisomy 18 and hepatoblastoma.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21113936     DOI: 10.1002/pbc.22768

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Hepatoblastoma in a mosaic trisomy 18 child with hemihypertrophy.

Authors:  Naveed Ahmad; Kate Wheeler; Helen Stewart; Carolyn Campbell
Journal:  BMJ Case Rep       Date:  2016-01-21

Review 2.  Hepatoblastoma in molecularly defined, congenital diseases.

Authors:  Gunther Nussbaumer; Martin Benesch
Journal:  Am J Med Genet A       Date:  2022-04-28       Impact factor: 2.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.